SAN CLEMENTE, Calif.--(BUSINESS WIRE)--A recent clinical trial published in the Journal of Clinical Gastroentology found that a probiotic combination of strains can significantly improve symptoms associated with functional bowel discomfort. The probiotic combination, found in Metagenics’ Ultra Flora Plus® DF supplement, could have a considerable impact on the quality of life for a number of people affected by these problems.
In the clinical trial, Lactobacillus acidophilus (NCFM strain) strain and the Bifidobacterium lactis (Bi-07) strain improved symptoms of abdominal bloating in patients with functional bowel issues, the most common gastrointestinal (GI) complaint.
Metagenics, a nutrigenomics and lifestyle medicine company focused on improving health, developed Ultra Flora Plus® DF with a probiotic (“good” bacteria) supplement containing pure strains of Lactobacillus acidophilus and Bifidobacterium lactis.
“Over 10 million people are treated each year for gastrointestinal (GI) complaints and the total health care costs exceed $40 billion annually,” said Jacob J. Kornberg, M.D., F.A.C.S., director of professional & clinical services at Metagenics, Inc. “The symptoms of GI disorders can cause discomfort and patients are unable to fully enjoy their lives.”
One in four Americans suffer from GI issues, including occasional constipation, bloating and cramping. GI issues such as these are those in which the bowel looks normal, but the nerves or muscles of the digestive tract do not function properly.
Unhealthy diets, low consumption of fiber, stress, use of medications and not enough exercise are some of the primary causes that can disrupt the body’s natural balance of “good” and “bad” bacteria. As a result, these factors affect digestion, waste elimination, immune health and the protective lining along the gastrointestinal tract. Symptoms generally include occasional heartburn, abdominal discomfort, mild nausea, occasional constipation, occasional loose stools and bloating.
“Bloating is the second most bothersome GI complaint and is one of the top three reasons patients seek medical care,” said Dr. Kornberg. “Metagenics’ Ultra Flora Plus® DF and other probiotic formulas manage GI symptoms and improve a patient’s general well-being.”
Metagenics offers other scientifically tested, high-potency probiotics that help address a range of GI complaints and support immune system function, including LactoViden ID® for upper GI support, Ultra Flora IB® for bowel irritation, LactoFlamX® for lower bowel distress, Proboulardi™ for acute immune support, and BifoViden ID® for lower GI health and intestinal motility support.
For more information about Ultra Flora Plus® DF and other Metagenics probiotic forumulas, visit www.metagenics.com.
About Metagenics, Inc.
Metagenics, Inc. (www.metagenics.com) is a nutrigenomics and lifestyle medicine company focused on reversing chronic illness and improving health. Founded in 1983, Metagenics serves more than 75,000 healthcare providers worldwide through premium quality, science-based medical foods, nutritional formulas, and lifestyle therapy programs to help their patients achieve a lifetime of good health. Metagenics’ scientific staff—among the largest in the nutrigenomics industry—has published more than 80 articles in peer-reviewed journals and has been awarded more than 50 international or domestic patents. The company’s educational arm, Metagenics University, collaborates with renowned medical experts to annually deliver more than 200 events designed to help healthcare professionals stay on the leading edge of lifestyle medicine and incorporate nutrition into their clinical practice.
Metagenics maintains its corporate headquarters in San Clemente, CA; R&D headquarters in Gig Harbor, WA; and operating subsidiaries in Brussels, Belgium and Brisbane, Australia.